Application And Comparative Analysis In SARS-Cov2 by PCR And CRISPR/Cas9
DOI:
https://doi.org/10.54097/hset.v45i.7389Keywords:
SARS-Cov2, PCR, CRISPR/Cas9, Nucleic Acid Testing.Abstract
COVID-19, a global large-scale epidemic caused by the novel coronavirus, is detrimental to people’s mental and physical health, and it also destruct the economic environment. In the process of the study of COVID-19, fast and accurate detective tools are necessary. There are plenty of clinical and laboratorial methods for detection. Nevertheless, due to various of realistic limitations, these methods cannot be fully applied clinically. This paper reviewed the some kinds of current polymerase chain reaction (PCR) technologies and the latest CRISPR/Cas9 in the detection of SARS-Cov2, compared the differences among these methods, and summarized the major achievements in cutting edge and limitations. In order to provide new ways to diagnose and cure the disease efficiently, and help doctors and researchers to investigate the complex pandemic and control the diffusion. PCR technology is the golden standard in the field of detecting COVID-19, while the high false negative rate and high requirements need to be improved. Many detective methods have been developed based on the CRISPR/Cas9 technology, each has its advantages, but also limited. In the future, the existing technology will be improved to explore the methods of mutual reference and combination between technologies, and find ways to improve the diagnostic efficiency and help clinical application, so as to provide help for the management of COVID-19 infection.
Downloads
References
WHO. Coronavirus disease situation dashboard.[2022-12-08].https://www.who.int/.
WHO Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: WHO. 2022. http://www.who.int/csr/sars/country/table2004_04_21/en/.
JD Sachs, et al. The Lancet Commission on Future Lessons from the COVID-19 Pandemic [J]. Lancet, 400 (2022): 1224-1280.
ZHANG Li-kun, et al. Application of PCR in the detection of novel coronavirus nucleicacid [J]. Journal of Medical Postgraduates, 2021, 34(5): 539-544.
Xiong Er-hu, et al. CRISPR/Cas9-mediated lateral flow detection of SARS-CoV-2 synchronous double gene diagnosis [J]. Angew Chem Int Ed Engl. 2021, 60(10):5307-5315.
Rai P, et al. Detection technologies and recent developments in the diagnosis of COVID-19 infection [J]. Appl Microbiol Biotechnol. 2021, 105(2):441-455.
HUANG Xiang-juan and HUANG Xiang-yan. Research on the application of SARS-Cov-2 detection technology [J]. Shandong Medical Journal, 2022, 62(21):90-94.
LI Kai-qiang, et al. Current status and prospects of CRISPR-Cas technology for nucleic acid detection [J]. Chinese Journal of Preventive Veterinary,2021,43(7):791-795.
Samson R, et al. Biosensors: frontiers in rapid detection of COVID-19[J]. 3 Biotech, 2020, 10(9):385.
GUO Zhao, et al. Porential value of droplet digital PCR in detection of SARS-CoV-2 [J]. Journal of Lanzhou University (Medical Sciences),2020,46(2):14-18.
Tin Marsic, et al. Vigilance: An engineered VirD2-Cas9 complex for SARS-CoV2 lateral flow detection [J]. Nano Letters, 2021, 21(8):3596-3603.
Jiao C, et al. non-canonical crRNAs derived from host transcripts enable multiplexable RNA detection by CRISPR/Cas9 [J]. Science, 2021, 372(6545):eabe7106.
Atze T Das, et al. Elimination of infectious HIV DNA by CRISPR–Cas9 [J]. Current Opinion in Virology, 2019, 38(C) : 81-88.
Li Hao, et al. Potent molecular target sites for Cas9 cleavage and mutational inactivation in the hepatitis B virus S gene [J]. International journal of biological sciences, 2016, 12(9) : 1104-1113.
James M. Readler, et al. Isoform specific editing of the coxsackievirus and adenovirus receptor [J]. Virology, 2019, 536(C) : 20-26.
Jianzhou Cui, et al. RNA-Sequencing-Based Transcriptomic Analysis Reveals a Role for Annexin-A1 in Classical and Influenza A Virus-Induced Autophagy [J]. Cells, 2020, 9(6).
Sun Shi-Hui, et al. A mouse model of SARS-CoV-2 infection and pathogenesis [J]. Cell Host & Microbe, 2020, 28(1) : 124-133.e4.
WANG Shan-shan, et al. Advances in the application of CRISPR-Cas system for SARS-CoV-2 diagnostic testing [J]. Chinese Journal of Viral Diseases,2022,12(04):304-310.
Manoucher Teymouri, et al.Recent advances and challenges of RT-PCR tests in the diagnosis of COVID-19 [J]. Pathology-Research and Practice, 2021, 221:153443.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







